Médecins - Prof. Dr. Prof. Dr. Muammer Kara | Gastroentérologie

Domaines cliniques

Maladies de l’œsophage, de l’estomac et de l’intestin.

Maladies du foie et du pancréas.

Endoscopie digestive et coloscopie.

Cholangiopancréatographie rétrograde endoscopique (CPRE).

Formation et spécialisation

Académie de médecine militaire Gülhane (GATA) — études médicales.

GATA — spécialisation en médecine interne et formation complémentaire en gastroentérologie.

Fonction actuelle

Medical Park Bursa — professeur de gastroentérologie.

Publications scientifiques sélectionnées

Yeniçeri M, Çakır Güney B, Küçük İ, Kara M, Yazgan Y, Kaplan M. Ülseratif kolitte hastalığın şiddetini öngörmede non-invaziv belirteçler olarak hematolojik parametrelerin değerlendirilmesi. J Med Palliat Care. 2020;1(3):53–57. DOI:10.47582/jompac.765810.

Cetindağlı I, Kara M, Tanoglu A, Ozalper V, Aribal S, Hancerli Y, Unal M, Ozarı O, Hira S, Kaplan M, Yazgan Y. Evaluation of endothelial dysfunction in patients with nonalcoholic fatty liver disease: Association of selenoprotein P with carotid intima-media thickness and endothelium-dependent vasodilation. Clin Res Hepatol Gastroenterol. 2017;41(5):516–524. DOI:10.1016/j.clinre.2017.01.005.

Küçük İ, Tanoğlu A, Öncü K, Yılmaz İ, Kara M, Beyazıt Y, Akyol T, Kaplan M, Özarı HO, Yazgan Y. Immunohistochemical activity of Prohibitin-2 and Stomatin-Like Protein-2 in patients with ulcerative colitis. Turk J Gastroenterol. 2016;27(3):233–238. DOI:10.5152/tjg.2016.15460.

Kara M, Dogru T, Genc H, Sertoglu E, Celebi G, Gurel H, Kayadibi H, Cicek AF, Ercin CN, Sonmez A. Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2015;27(10):1144–1148. DOI:10.1097/MEG.0000000000000405.

Kara M, Tanoglu A, Kutlu A, Sirkeci O, Kekilli M. Esomeprazole: a safe alternative to lansoprazole allergy? Iran J Allergy Asthma Immunol. 2014;13(4):296–297. PMID:24659167.

Kara M, Erdal M. Sıklığı Artan Bir Halk Sağlığı Sorunu: Non-Alkolik Yağlı Karaciğer Hastalığı. TAF Prev Med Bull. 2014;13(1):65–76.

Genc H, Dogru T, Kara M, Tapan S, Ercin CN, Acikel C, Karslioglu Y, Bagci S. Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease. Ann Hepatol. 2013;12(4):548–555. PMID:23813132.